Newlink Genetics reported 3.38M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US $ 21.38M 4.73M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Capricor Therapeutics CAPR:US 1.8M 10.66K
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Eli Lilly And LLY:US $ 1.58B 107.8M
Idera Pharmaceuticals IDRA:US $ 2.33M 141K
Intrexon XON:US $ 18.66M 1.34M
Merk MRK:US $ 2.27B 9M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Newlink Genetics NLNK:US 3.38M 1.18M
Pfizer PFE:US $ 2.73B 61M
Prothena PRTA:US 11.96M 923K
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Vascular Biogenics VBLT:US 1.62M 144K
YTE INCY:US $ 190.7M 21.84M